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1. Introduction {#sim6779-sec-0001}
===============

Joint modelling of longitudinal and survival data has been extensively studied in the methodological literature, as it provides an efficient method to not only account for measurement error in a longitudinal biomarker included in a survival analysis but also alternatively account for informative dropout when the longitudinal process is of primary interest [1](#sim6779-bib-0001){ref-type="ref"}, [2](#sim6779-bib-0002){ref-type="ref"}. It has been shown through simulation that simply including the observed longitudinal outcome as a time‐varying covariate in a survival analysis can severely underestimate the true association [3](#sim6779-bib-0003){ref-type="ref"}. The most common form of joint model uses shared parameters, which links the longitudinal and survival components through random effects. With the increasing availability of user‐friendly software [4](#sim6779-bib-0004){ref-type="ref"}, [5](#sim6779-bib-0005){ref-type="ref"}, [6](#sim6779-bib-0006){ref-type="ref"}, [7](#sim6779-bib-0007){ref-type="ref"}, this form of joint model is beginning to find its place in applied clinical research [2](#sim6779-bib-0002){ref-type="ref"}, [8](#sim6779-bib-0008){ref-type="ref"}, [9](#sim6779-bib-0009){ref-type="ref"}. However, there is a multitude of further research needed, in particular, to utilise joint models fully in application to registry‐based datasets.

In this article, we incorporate delayed entry (left truncation) into the standard joint model framework, an aspect that has received relatively limited attention. Delayed entry occurs when a patient is not at risk of the event of interest until a time *t* \> 0. Within a survival analysis setting, this occurs, for example, when using age as the timescale, which can be an improved way of controlling for the effect of age [10](#sim6779-bib-0010){ref-type="ref"}. Here, we can draw parallels with the challenges that arise when incorporating random effects into a delayed entry survival model [11](#sim6779-bib-0011){ref-type="ref"}, [12](#sim6779-bib-0012){ref-type="ref"}. Not only do we have the 'weeding out' process induced by the frailties, where patients with smaller frailties are more likely to have longer survival times, but the delayed entry causes a second selection issue, where patients with smaller frailties are more likely to reach the threshold set by an entry time.

Standard shared frailty survival models allowing delayed entry have received limited attention, which is particularly highlighted by the limited availability of software. The extensive `frailtypack` [13](#sim6779-bib-0013){ref-type="ref"} in R allows left truncation with clustered survival times, in particular, a shared frailty model [14](#sim6779-bib-0014){ref-type="ref"}, an additive frailty model with two correlated random effects (intercept and slope) [15](#sim6779-bib-0015){ref-type="ref"} and a nested frailty model with two levels of clustering allowing for independent gamma distributed random effects [16](#sim6779-bib-0016){ref-type="ref"}.

Incorporating delayed entry into the framework of joint longitudinal‐survival models has also received limited attention. Dantan *et al.* developed a joint model for longitudinal data and an illness--death process in cognitive ageing [17](#sim6779-bib-0017){ref-type="ref"}. They also allowed for an intermediate pre‐diagnosis state through a random change point. Estimation was conducted through maximum likelihood, using non‐adaptive Gauss--Hermite quadrature to evaluate analytically intractable integrals, using 20‐point quadrature in their simulation study, and state that use of fewer points leads to bias. Piccorelli and Schluchter [18](#sim6779-bib-0018){ref-type="ref"} developed an expectation--maximization algorithm to jointly model repeatedly measured pulmonary function (FEV1% predicted) and survival in cystic fibrosis patients using registry data. Not all patients were followed from birth, which subsequently results in left truncation when using age as the timescale. They assumed a linear mixed effects model for the longitudinal outcome, with random intercept and slope, which, along with a transformation of age at death, were assumed to follow a trivariate normal distribution. Van den Hout and Muniz‐Terrera [19](#sim6779-bib-0019){ref-type="ref"} developed a joint model for repeatedly measured discrete data, arising from tests of cognitive function, and survival in the analysis of an older population. They allowed for a random intercept and linear slope in the longitudinal submodel, assessing a binomial or beta‐binomial formulation, and a Weibull or Gompertz survival model. As interest was in prediction, they emphasised the benefits of adopting a parametric survival submodel. They looked at specific association structures to ensure that the cumulative hazard function could be calculated analytically and used 13‐point non‐adaptive Gauss--Hermite quadrature to integrate out the random effects. Within the alternative joint latent class modelling framework, Proust‐Lima *et al.* incorporated delayed entry into a joint model of multivariate longitudinal outcomes and a time to event [20](#sim6779-bib-0020){ref-type="ref"}.

The previous approaches described earlier can be considered limited to a random intercept and single random linear slope in the longitudinal submodel and standard parametric choices such as the Weibull or Gompertz for the survival submodel. Limited association structures, describing how the longitudinal and survival components are linked, were also implemented. Furthermore, the choice of non‐adaptive quadrature can be highly computationally intensive, particularly as a large number of quadrature points have been shown to be required to obtain appropriate standard errors [21](#sim6779-bib-0021){ref-type="ref"}. In this article, we emphasise the use of flexible parametric approaches, where in particular, we propose to incorporate fixed and random effect polynomials of time into the longitudinal submodel. This generalises previous approaches, allowing a highly flexible way of capturing nonlinear trajectories of the longitudinal outcome over time. Furthermore, to allow flexibility in parametric survival submodel formulations, we propose to model the baseline log hazard function using restricted cubic splines, which can capture multiple turning points/more complex shapes in the underlying event rate [22](#sim6779-bib-0022){ref-type="ref"}, [23](#sim6779-bib-0023){ref-type="ref"}. The extension to delayed entry requires a second set of numerical integration, beyond that required in a standard joint model, to evaluate the likelihood, which we propose to evaluate using fully adaptive Gauss--Hermite quadrature.

The clinical example that we use to illustrate this work comes from a study in breast cancer [24](#sim6779-bib-0024){ref-type="ref"}, where interest is in investigating the association between changes in mammographic density after diagnosis, and the time to death due to breast cancer. Mammographic density, which reflects the amount of fibroglandular tissue in the breast, is one of the strongest risk factors for breast cancer [25](#sim6779-bib-0025){ref-type="ref"}. It has also been suggested that, in women diagnosed with breast cancer, change in mammography density over time may be associated with prognosis/response to treatment [24](#sim6779-bib-0024){ref-type="ref"}, [26](#sim6779-bib-0026){ref-type="ref"}. The original study of Li *et al.* considered only the first two measurements/mammograms (diagnosis and follow‐up) to focus on the relationship between early response to treatment (in terms of mammography density change) and survival. We now re‐analyse the data and include information on all available measurements during follow‐up. Given that all patients have at least two measurements, by definition they cannot experience the event of interest until after the time of second measurement. Therefore, analysis requires delayed entry to be accounted for; however, we can still incorporate the baseline mammographic density measurement prior to entry within the longitudinal submodel.

In Section [2](#sim6779-sec-0002){ref-type="sec"}, we derive a joint model, incorporating delayed entry and flexible parametric formulations for the longitudinal trajectory, and baseline hazard function. In Section [3](#sim6779-sec-0007){ref-type="sec"}, we describe the estimation approach using adaptive Gauss--Hermite quadrature. In Section [4](#sim6779-sec-0008){ref-type="sec"}, we conduct a simulation study to (i) evaluate the performance of fully adaptive Gauss--Hermite quadrature, comparing with previously proposed non‐adaptive quadrature, and (ii) investigate the impact of misspecification of the longitudinal trajectory on estimates of association. In Section [5](#sim6779-sec-0011){ref-type="sec"}, we illustrate the methods in application to the breast cancer dataset, investigating the association between change in mammographic density over time and breast cancer survival. We describe user‐friendly Stata software, written by the first author, which was used to fit all the models in this paper, and describe a variety of other models available in the [Supporting Information](#sim6779-supinf-0001){ref-type="supplementary-material"}. We conclude the paper in Section [6](#sim6779-sec-0012){ref-type="sec"} with a discussion.

2. Model framework and likelihood {#sim6779-sec-0002}
=================================

We begin with some notation. Let *T* ~*i*~ be the observed survival time of the *i*th patient, where *i* = 1,...,*n*, with *T* ~*i*~=min(*S* ~*i*~,*C* ~*i*~), the minimum of the true survival time, *S* ~*i*~, and *C* ~*i*~ the censoring time. We define an event indicator *d* ~*i*~, which takes the value of 1 if *S* ~*i*~≤*C* ~*i*~ and 0 otherwise. We also have *T* ~0*i*~, the time at which a patient becomes at risk of the event, with *T* ~0*i*~\<*T* ~*i*~. Let *y* ~*ij*~={*y* ~*i*~(*t* ~*ij*~),*j* = 1,...,*n* ~*i*~} denote the observed longitudinal responses, with *y* ~*i*~(*t* ~*ij*~) the *j*th observed longitudinal response of a continuous biomarker for the *i*th patient taken at time *t* ~*ij*~. Each patient has *n* ~*i*~ repeated measures. We further define a vector of time‐independent baseline covariates, ***U*~*i*~**. To maintain flexibility, different subsets of ***U*~*i*~** can be included in either the longitudinal or survival submodels. We define a vector of patient‐specific random effects, ***b*** ~*i*~, which serve to capture the correlation between measurements of the same patient and the association between the longitudinal and survival outcomes.

2.1. Model framework {#sim6779-sec-0003}
--------------------

### 2.1.1. Longitudinal submodel {#sim6779-sec-0004}

We assume a linear mixed effects model for the continuous longitudinal outcome, with $$y_{i}\left( t_{ij} \right) = m_{i}\left( t_{ij} \right) + \varepsilon_{ij},\qquad\varepsilon_{ij} \sim N\left( {0,\sigma_{e}^{2}} \right)$$ $$m_{i}\left( t_{ij} \right) = \mathbf{X}_{i}^{T}\left( t_{ij} \right)\mathbf{\beta} + \mathbf{Z}_{i}^{T}\left( t_{ij} \right)\mathbf{b}_{i} + \mathbf{u}_{i}^{T}\mathbf{\delta}$$ where ***X*** ~*i*~ and ***Z*** ~*i*~ are design matrices for the fixed (***β***) and random effects (***b*** ~*i*~), respectively. Baseline covariates can be included, represented by ***u*** ~*i*~, with a vector of corresponding regression coefficients, ***δ***. Measurement error is incorporated through *ε* ~*ij*~, which we assume is independent to the random effects. We also assume that cov(*ε* ~*ij*~,*ε* ~*ik*~) = 0 (where *j* ≠ *k*).

Previously joint models with delayed entry have assumed a linear growth curve (random intercept and random linear slope); however, here, we wish to generalise to allow for the possibility of nonlinear trajectories by allowing both ***X*** ~*i*~ and ***Z*** ~*i*~ to contain (fractional) polynomial functions of time [27](#sim6779-bib-0027){ref-type="ref"}. Alternatively, we could use restricted cubic splines; however, in this article, we concentrate on the use of polynomials, but splines may be used in the associated Stata software ([Supporting Information](#sim6779-supinf-0001){ref-type="supplementary-material"}).

### 2.1.2. Survival submodel {#sim6779-sec-0005}

We define the proportional hazards survival submodel $$h_{i}\left( t \right) = \exp\left\lbrack {s\left( \log\left( t \right) \middle| \mathbf{\gamma},\mathbf{k}_{0} \right) + \mathbf{\psi}^{T}\mathbf{v}_{i} + \alpha_{1}m_{i}\left( t \right)} \right\rbrack$$ where *s*(log(*t*)\|***γ***,***k*** ~0~) is a restricted cubic spline function of log(*t*), that is, the log baseline hazard function with knot vector ***k*** ~0~ and coefficient vector ***γ***. Using splines to model the baseline log hazard function can provide a very flexible framework to capture turning points in the underlying hazard function, while the restricted nature ensures a sensible form in the tails, that is, linearity is imposed beyond the boundary knots that are placed at the minimum and maximum event times. Further details on this form of survival model can be found elsewhere [22](#sim6779-bib-0022){ref-type="ref"}, [23](#sim6779-bib-0023){ref-type="ref"}. A recent extensive simulation study showed that the AIC and BIC can be used to guide knot selection effectively [28](#sim6779-bib-0028){ref-type="ref"}. We also have ***v*** ~*i*~∈***U*** ~*i*~, which is a set of baseline covariates with associated vector of log hazard ratios, ***ψ***, and *α* ~1~ is termed the association parameter, representing a log hazard ratio for a one‐unit increase in the longitudinal outcome at time *t*. This association is termed the current value association structure, which is one of the many ways to link the longitudinal and survival components. In the illustrative breast cancer example, we study how the rate of change of mammographic density is associated with survival, which can be investigated using the following association structure: $$h_{i}\left( t \right) = \exp\left\lbrack {s\left( \log\left( t \right) \middle| \mathbf{\gamma},\mathbf{k}_{0} \right) + \mathbf{\psi}^{T}\mathbf{v}_{i} + \alpha_{2}\underset{i}{\overset{\prime}{m}}\left( t \right)} \right\rbrack$$ where $$m_{i}^{\prime}\left( t \right) = \frac{d}{dt}m_{i}\left( t \right)$$ The interpretation of *α* ~2~ under the slope association is the log hazard ratio for a one‐unit increase in the rate of change of the longitudinal outcome at time *t*. Both the current value and slope associations can be considered time‐dependent association structures, and therefore, it is of direct interest to investigate the impact of model misspecification in terms of capturing the longitudinal trajectory and how it impacts on the estimates of association, our *α* parameters. Other association structures have been studied, for example, time‐independent structures, linking say the random intercept; however, we refer the reader elsewhere for further details [29](#sim6779-bib-0029){ref-type="ref"}, [30](#sim6779-bib-0030){ref-type="ref"}.

2.2. Likelihood {#sim6779-sec-0006}
---------------

We define the parameter vector to be ***θ***={***θ*** ~*t*~,***θ*** ~*y*~,***θ*** ~*b*~}. The likelihood for the *i*th patient, *L* ~*i*~, conditional on entry time *T* ~0*i*~, can be written as $$L_{i} = \frac{\int p\left( T_{i},d_{i} \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right)\left\lbrack {\prod\limits_{j = 1}^{n_{i}}p\left( y_{ij} \middle| \mathbf{b}_{i},\mathbf{\theta}_{y} \right)} \right\rbrack p\left( \mathbf{b}_{i} \middle| \mathbf{\theta}_{b} \right)d\mathbf{b}_{i}}{S\left( T_{0i} \middle| \mathbf{\theta} \right)}$$ where $$S\left( T_{0i} \middle| \mathbf{\theta}_{t} \right) = \int S\left( T_{0i} \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right)p\left( \mathbf{b}_{i} \middle| \mathbf{\theta}_{b} \right)d\mathbf{b}_{i}$$ The numerator in Equation [(5)](#sim6779-disp-0006){ref-type="disp-formula"} is the likelihood under a standard joint model, with the addition being the denominator due to the delayed entry aspect.

Assuming a continuous normally distributed longitudinal outcome, we have $$p\left( y_{ij} \middle| \mathbf{b}_{i},\mathbf{\theta}_{y} \right) = \left( 2\pi\sigma_{e}^{2} \right)^{- 1/2}\exp\left\lbrack {- \frac{\left\lbrack y_{i}\left( t_{ij} \right) - m_{i}\left( t_{ij} \right) \right\rbrack^{2}}{2\underset{e}{\overset{2}{\sigma}}}} \right\rbrack$$ and assuming normally distributed random effects gives $$p\left( \mathbf{b}_{i} \middle| \mathbf{\theta}_{b} \right) = \left( 2\pi \middle| \mathbf{\Sigma} \middle| \right)^{- Q/2}\exp\left\lbrack {- \frac{\underset{i}{\overset{T}{\mathbf{b}}}\mathbf{\Sigma}^{- 1}\mathbf{b}_{i}}{2}} \right\rbrack$$ with variance--covariance matrix, ***Σ***, where *Q* is the dimension of the random effects. Under a proportional hazards survival model, we have $$\begin{matrix}
{p\left( T_{i},d_{i} \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right)} & {= h\left( T_{i} \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right)^{d_{i}} \times S\left( T_{i} \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right)} \\
{= h\left( T_{i} \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right)^{d_{i}} \times \exp\left( {- \int\limits_{0}^{T_{i}}h\left( u \middle| \mathbf{b}_{i},\mathbf{\theta}_{t} \right){du}} \right)} & \\
\end{matrix}$$ with *h*() defined in Equation [(3)](#sim6779-disp-0003){ref-type="disp-formula"} or [(4)](#sim6779-disp-0004){ref-type="disp-formula"}. Maximising the likelihood in Equation [(5)](#sim6779-disp-0006){ref-type="disp-formula"} is a computationally challenging task, as integrating out the random effects, in both the numerator and denominator, requires separate numerical integration. Furthermore, each set of numerical integration has a nested integral required to calculate the cumulative hazard function and subsequently the survival function, because of the use of splines to model the log baseline hazard function. However, this is also often required when using time‐dependent association structures combined with standard parametric choices for the baseline hazard, such as the Weibull [6](#sim6779-bib-0006){ref-type="ref"}.

3. Estimation {#sim6779-sec-0007}
=============

The overall log likelihood, *L*, is given by $$\log L = \sum\limits_{i = 1}^{n}\log L_{i}$$ and can be maximised using the Newton--Raphson technique in the ml engine in Stata, with derivatives calculated using finite differences. However, we must employ numerical integration techniques to calculate the joint likelihood. The implementation of adaptive quadrature has been shown to be far superior to non‐adaptive within a standard joint model context [21](#sim6779-bib-0021){ref-type="ref"}. With the extension to delayed entry, this requires a second set of numerical integration, to be conducted simultaneously, in order to calculate the denominator in Equation [(5)](#sim6779-disp-0006){ref-type="disp-formula"}.

We briefly describe our implementation of adaptive quadrature to evaluate the joint likelihood [31](#sim6779-bib-0031){ref-type="ref"}, [32](#sim6779-bib-0032){ref-type="ref"}, [33](#sim6779-bib-0033){ref-type="ref"}. Beginning with the numerator in Equation [(5)](#sim6779-disp-0006){ref-type="disp-formula"}, which is equivalent to the joint likelihood when delayed entry is not present, the integrals can be evaluated employing adaptive Gauss--Hermite quadrature. Following [32](#sim6779-bib-0032){ref-type="ref"}, consider the kernel normal distribution of $\phi\left( \mathbf{b}_{i} \middle| \mathbf{\hat{b}}_{i},\mathbf{\hat{\Omega}}_{i} \right)$, multiplying and dividing the numerator of Equation [(5)](#sim6779-disp-0006){ref-type="disp-formula"} by the kernel give $$\begin{matrix}
{p\left( T_{i},d_{i},\mathbf{y}_{i};\mathbf{\theta} \right)} & {= \int p\left( T_{i},d_{i} \middle| \mathbf{b}_{i};\mathbf{\theta}_{t} \right)\left\lbrack {\prod\limits_{j = 1}^{n_{i}}p\left\{ y_{i}\left( t_{ij} \right) \middle| \mathbf{b}_{i};\mathbf{\theta}_{y} \right\}} \right\rbrack p\left( \mathbf{b}_{i};\mathbf{\theta}_{b} \right)\text{d}\mathbf{b}_{i}} \\
{= \int\frac{p\left( T_{i},d_{i} \middle| \mathbf{b}_{i};\mathbf{\theta}_{t} \right)\left\lbrack {\prod\limits_{j = 1}^{n_{i}}p\left\{ y_{i}\left( t_{ij} \right) \middle| \mathbf{b}_{i};\mathbf{\theta}_{y} \right\}} \right\rbrack p\left( \mathbf{b}_{i};\mathbf{\theta}_{b} \right)}{\phi\left( \mathbf{b}_{i} \middle| \mathbf{\hat{b}}_{1i},\mathbf{\hat{\Omega}}_{1i} \right)}\phi\left( \mathbf{b}_{i} \middle| \mathbf{\hat{b}}_{1i},\mathbf{\hat{\Omega}}_{1i} \right)\text{d}\mathbf{b}_{i}} & \\
\end{matrix}$$ with subject‐specific random effect posterior means and variance--covariance matrices, $\mathbf{\hat{b}}_{1i}$ and $\mathbf{\hat{\Omega}}_{1i}$. Equation [(11)](#sim6779-disp-0012){ref-type="disp-formula"} can then be evaluated using Gauss--Hermite quadrature using this alternative normal kernel density, with the nodes appropriately transformed using $\mathbf{\hat{r}}_{1i} = \mathbf{\hat{b}}_{1i} + \mathbf{\hat{\Omega}}_{1i}^{1/2}\mathbf{d}_{b_{1},\ldots,b_{Q}}$, where $\mathbf{d}_{b_{1},\ldots,b_{Q}}$ are the vector of nodes based on the multivariate standard normal kernel, which is pre‐multiplied by the Cholesky decomposition of the estimated subject‐specific variance--covariance matrix of the random effects, $\mathbf{\hat{\Omega}}_{1i}^{1/2}$.

This gives $$\begin{matrix}
{p\left( T_{i},d_{i},\mathbf{y}_{i};\mathbf{\theta} \right)} & \left. \approx \left( 2\pi \right)^{Q/2} \middle| \mathbf{\hat{\Omega}}_{1i}|^{1/2}\sum\limits_{b_{1} = 1}^{m}\ldots\sum\limits_{b_{Q} = 1}^{m}p\left( T_{i},d_{i} \middle| \mathbf{\hat{r}}_{1i};\mathbf{\theta}_{t} \right)\left\lbrack {\prod\limits_{j = 1}^{n_{i}}p\left\{ y_{i}\left( t_{ij} \right) \middle| \mathbf{\hat{r}}_{1i};\mathbf{\theta}_{y} \right\}} \right\rbrack \right. \\
{\quad \times \phi\left( \mathbf{\hat{r}}_{1i} \middle| \mathbf{0},\mathbf{\Sigma} \right)\exp\left( {\frac{1}{2}\underset{b_{1},\ldots,b_{Q}}{\overset{T}{\mathbf{d}}}\mathbf{d}_{b_{1},\ldots,b_{Q}}} \right)\prod\limits_{q = 1}^{Q}v_{b_{q}}} & \\
\end{matrix}$$ where $v_{b_{q}}$ are the quadrature weights from the standard normal kernel. Similarly, the denominator in Equation [(5)](#sim6779-disp-0006){ref-type="disp-formula"} can be evaluated using a separate set of adaptive Gauss--Hermite quadrature as follows, where $$\begin{matrix}
{S\left( T_{0i} \middle| \mathbf{\theta} \right)} & {= \int S\left( T_{0i} \middle| \mathbf{b}_{i},\mathbf{\theta} \right)p\left( \mathbf{b}_{i} \middle| \mathbf{\theta}_{t} \right)\text{d}\mathbf{b}_{i}} \\
{= \int\frac{S\left( T_{0i} \middle| \mathbf{b}_{i},\mathbf{\theta} \right)p\left( \mathbf{b}_{i} \middle| \mathbf{\theta}_{t} \right)}{\phi\left( \mathbf{b}_{i} \middle| \mathbf{\hat{b}}_{2i},\mathbf{\hat{\Omega}}_{2i} \right)}\phi\left( \mathbf{b}_{i} \middle| \mathbf{\hat{b}}_{2i},\mathbf{\hat{\Omega}}_{2i} \right)\text{d}\mathbf{b}_{i}} & \\
\left. \approx \left( 2\pi \right)^{Q/2} \middle| \mathbf{\hat{\Omega}}_{2i}|^{1/2}\sum\limits_{b_{1} = 1}^{m}\ldots\sum\limits_{b_{Q} = 1}^{m}S\left( T_{0i} \middle| \mathbf{\hat{r}}_{2i};\mathbf{\theta}_{t} \right)\phi\left( \mathbf{\hat{r}}_{2i} \middle| \mathbf{0},\mathbf{\Sigma} \right)\exp\left( {\frac{1}{2}\underset{b_{1},\ldots,b_{Q}}{\overset{T}{\mathbf{d}}}\mathbf{d}_{b_{1},\ldots,b_{Q}}} \right)\prod\limits_{q = 1}^{Q}v_{b_{q}} \right. & \\
\end{matrix}$$ where $\mathbf{\hat{r}}_{2i} = \mathbf{\hat{b}}_{2i} + \mathbf{\hat{\Omega}}_{2i}^{1/2}\mathbf{d}_{b_{1},\ldots,b_{Q}}$.

We implement the following algorithm: Obtain starting values for ***θ*** ^0^. These are obtained by fitting a separate linear mixed effects model, obtaining patient‐specific predictions from the mixed effects model and including them as a time‐varying covariate within a standard survival model (this assumes the current value association but is appropriately altered under different association structures). This is a computationally efficient way of obtaining excellent starting values for the full joint model. We also obtain initial values for the quadrature node locations, ${\hat{\mathbf{b}}}_{1i}^{0}$ and ${\hat{\Omega}}_{1i}^{0}$ using empirical Bayes predictions of the random effects from the same separate linear mixed effects model, and use a default of **0** and **1** for ${\hat{\mathbf{b}}}_{2i}^{0}$ and ${\hat{\Omega}}_{2i}^{0}$.Repeat for *k* = 1,2,... until Newton--Raphson iterations have converged. Predict the subject‐specific posterior means and standard deviations, $\left\{ {\hat{\mathbf{b}}}_{1i}^{k},{\hat{\mathbf{b}}}_{2i}^{k} \right\}$ and $\left\{ \mathbf{\hat{\Omega}}_{1i}^{k},\mathbf{\hat{\Omega}}_{2i}^{k} \right\}$: Predict the subject‐specific posterior means and standard deviations, $\left\{ {\hat{\mathbf{b}}}_{1i}^{k0},{\hat{\mathbf{b}}}_{2i}^{k0} \right\}$ and $\left\{ \mathbf{\hat{\Omega}}_{1i}^{k0},\mathbf{\hat{\Omega}}_{2i}^{k0} \right\}$ using adaptive quadrature based on previous estimates, $\left\{ {\hat{\mathbf{b}}}_{1i}^{k - 1},{\hat{\mathbf{b}}}_{2i}^{k - 1} \right\}$ and $\left\{ \mathbf{\hat{\Omega}}_{1i}^{k - 1},\mathbf{\hat{\Omega}}_{2i}^{k - 1} \right\}$.Repeat for *j* = 1,2,... until convergence: Predict the subject‐specific posterior means and standard deviations, $\left\{ {\hat{\mathbf{b}}}_{1i}^{kj},{\hat{\mathbf{b}}}_{2i}^{kj} \right\}$ and $\left\{ \mathbf{\hat{\Omega}}_{1i}^{kj},\mathbf{\hat{\Omega}}_{2i}^{kj} \right\}$ using adaptive quadrature based on previous estimates, $\left\{ {\hat{\mathbf{b}}}_{1i}^{k(j - 1)},{\hat{\mathbf{b}}}_{2i}^{k(j - 1)} \right\}$ and $\left\{ \mathbf{\hat{\Omega}}_{1i}^{k(j - 1)},\mathbf{\hat{\Omega}}_{2i}^{k(j - 1)} \right\}$.Update the parameter estimates to ***θ*** ~*k*~ using adaptive quadrature using $\left\{ {\hat{\mathbf{b}}}_{1i}^{k},{\hat{\mathbf{b}}}_{2i}^{k} \right\}$ and $\left\{ \mathbf{\hat{\Omega}}_{1i}^{k},\mathbf{\hat{\Omega}}_{2i}^{k} \right\}$.

We use a tolerance of 1.0E − 08 for the convergence of the quadrature node locations in the *j* iterations and standard convergence criteria for the *k* iterations, that is, the full Newton--Raphson iterations.

4. Simulation study {#sim6779-sec-0008}
===================

In this section, we conduct a simulation study with two primary aims: (i) to investigate the performance of fully adaptive Gauss--Hermite quadrature in calculating the joint likelihood with delayed entry, comparing with previously proposed non‐adaptive quadrature, and (ii) to investigate the impact of misspecification of the longitudinal trajectory on estimates of association.

We assume the following longitudinal trajectory: $$m_{i}\left( t \right) = \left( \beta_{0} + b_{0i} \right) + \left( \beta_{1} + b_{1i} \right)t + \beta_{2}t^{2} + \beta_{3}t^{3}$$ where $$\begin{pmatrix}
b_{0i} \\
b_{1i} \\
\end{pmatrix} = \text{N}\left( {\begin{bmatrix}
0 \\
0 \\
\end{bmatrix},\begin{bmatrix}
\sigma_{0}^{2} & {\rho\sigma_{0}\sigma_{1}} \\
{\rho\sigma_{0}\sigma_{1}} & \sigma_{1}^{2} \\
\end{bmatrix}} \right)$$ that is, a random intercept and random linear slope with fixed squared and cubic powers of time. To investigate the impact of misspecifying the longitudinal submodel on estimates of association, we simulate scenarios using either the current value structure shown in Equation [(3)](#sim6779-disp-0003){ref-type="disp-formula"} or the rate of change structure shown in Equation [(4)](#sim6779-disp-0004){ref-type="disp-formula"}. This allows us to directly compare their robustness. Therefore, we simulate under the following survival submodel, with a Weibull baseline hazard function and current value structure, $$h_{i}\left( t \right) = {\lambda\gamma}t^{\gamma - 1}\exp\left\lbrack {\alpha_{1}\left( {\beta_{0} + b_{0i} + \left( \beta_{1} + b_{1i} \right)t + \beta_{2}t^{2} + \beta_{3}t^{3}} \right)} \right\rbrack$$ or the rate of change structure, $$h_{i}\left( t \right) = {\lambda\gamma}t^{\gamma - 1}\exp\left\lbrack {\alpha_{2}\left( {\beta_{1} + b_{1i} + 2\beta_{2}t + 3\beta_{3}t^{2}} \right)} \right\rbrack$$ Parameter values are given as follows: *β* ~0~=4.348, *β* ~1~=−0.239, *β* ~2~=0.0264, *β* ~3~=−0.00108, *σ* ~0~=1.143, *σ* ~1~=0.0704, *ρ* =− 0.0923, *λ* = 0.00574 and *γ* = 1.197. These were based on fitting separate survival and longitudinal models to the breast cancer dataset to provide plausible functions from which to simulate. The assumed true underlying baseline hazard function, longitudinal trajectory and rate of change of the longitudinal trajectory are shown in Figure [1](#sim6779-fig-0001){ref-type="fig"}.

![Assumed functions based on models applied to the breast cancer data to inform the simulation study.](SIM-35-1193-g001){#sim6779-fig-0001}

In scenarios that assume the current value structure, we vary *α* ~1~={0.1,0.25,0.5}, and in scenarios that assume the rate of change structure, we vary *α* ~2~={1,2,3}. Survival times are simulated using the general survival simulation algorithm of Crowther and Lambert [34](#sim6779-bib-0034){ref-type="ref"}. In each simulation, 1000 patient survival times are generated using Equation [(16)](#sim6779-disp-0017){ref-type="disp-formula"} or [(17)](#sim6779-disp-0018){ref-type="disp-formula"}, with accompanying entry times generated from a uniform distribution *U*(0,3). Any patients whose survival time is less than their entry time are deleted. Observed longitudinal measurements are then simulated at a patient\'s entry time and annually thereafter, with up to 10 measurements per patient, from $N\left( m_{i}\left( t \right),\sigma_{e}^{2} \right)$, where *σ* ~*e*~=0.591. Finally, administrative censoring is applied at 15 years. Any measurements simulated after the patients survival/censoring time are deleted.

To each simulated dataset under each set of parameter values, we apply both the joint model defined by Equations [(14)](#sim6779-disp-0015){ref-type="disp-formula"}--[(16)](#sim6779-disp-0017){ref-type="disp-formula"} or [(17)](#sim6779-disp-0018){ref-type="disp-formula"}, that is, the true model (either current value or rate of change structure, as appropriate) and a joint model assuming just a random intercept and random linear slope in the longitudinal submodel, with no squared or cubic fixed effect time terms to assess the impact of misspecifying the trajectory. Each model is applied using 5‐point adaptive Gauss--Hermite and 5‐point and 15‐point non‐adaptive quadrature. We conduct 200 repetitions of each simulation scenario and present results in Tables [1](#sim6779-tbl-0001){ref-type="table-wrap"} and [2](#sim6779-tbl-0002){ref-type="table-wrap"}. Bias, percentage bias and coverage are calculated on the parametrised scales, for example, standard deviations and the shape and scale parameters are on the log scale, and the correlation between the random intercept and slope is parametrised using the inverse hyperbolic tangent transformation (this is the standard parametrisation used in Stata for correlation parameters [35](#sim6779-bib-0035){ref-type="ref"}).

###### 

Simulation results of bias, percentage bias, coverage and mean square error of all parameters from current value association structure scenarios.

  Scenario   Parameter        Truth    5‐point adaptive quadrature   5‐point non‐adaptive quadrature   15‐point non‐adaptive quadrature                                                                                                                                                                            
  ---------- ---------------- -------- ----------------------------- --------------------------------- ---------------------------------- ------- -------- -------- ------ ------- -------- --------- ------ ------- -------- --------- ------ ------- -------- --------- ------ ------- -------- --------- ------ -------
  1          *β* ~0~          4.348    −0.002                        −0.04                             95.0                               0.002   −0.308   −7.08    0.0    0.096   −0.004   −0.10     66.0   0.009   −0.312   −7.18     1.0    0.105   −0.002   −0.04     90.0   0.003   −0.308   −7.08     0.0    0.097
             *β* ~1~          −0.239   0.000                         −0.02                             93.0                               0.001   0.180    −75.22   0.0    0.032   0.000    −0.04     93.0   0.001   0.180    −75.33    0.0    0.032   0.000    −0.03     92.0   0.001   0.180    −75.27    0.0    0.032
             log(*σ* ~0~)     0.133    −0.002                        0.08                              94.0                               0.002   0.008    −0.32    94.5   0.002   −0.371   13.96     0.0    0.142   −0.358   13.49     0.0    0.133   −0.031   1.17      89.5   0.003   −0.021   0.78      93.5   0.003
             log(*σ* ~1~)     −2.654   −0.002                        −1.30                             95.0                               0.001   0.001    0.53     94.5   0.001   −0.147   −110.18   0.5    0.023   −0.146   −109.33   0.5    0.023   −0.038   −28.57    62.5   0.002   −0.038   −28.54    60.0   0.002
             atanh(*ρ*)       −0.093   0.004                         −4.60                             96.0                               0.002   −0.005   5.77     96.5   0.002   0.307    −331.48   0.0    0.095   0.302    −326.01   0.0    0.092   0.138    −148.65   0.0    0.020   0.131    −142.09   0.0    0.018
             log(*σ* ~*e*~)   −0.526   0.000                         −0.01                             93.0                               0.000   0.006    −1.12    87.0   0.000   0.040    −7.57     0.0    0.002   0.046    −8.66     0.0    0.002   0.004    −0.72     91.5   0.000   0.010    −1.86     75.0   0.000
             log(*λ*)         −5.160   −0.021                        0.41                              94.0                               0.230   −0.025   0.48     95.0   0.227   −0.020   0.39      94.0   0.231   −0.029   0.56      94.0   0.228   −0.021   0.41      94.5   0.229   −0.025   0.48      95.0   0.227
             log(*γ*)         0.180    −0.005                        −2.78                             94.5                               0.011   −0.004   −2.22    95.5   0.011   −0.004   −2.22     95.0   0.011   −0.004   −2.22     95.0   0.011   −0.005   −2.78     95.0   0.011   −0.004   −2.22     95.5   0.011
             *α*              0.100    0.008                         8.00                              95.5                               0.004   0.009    9.00     95.5   0.004   0.008    8.00      96.5   0.004   0.010    10.00     96.0   0.004   0.008    8.00      95.0   0.004   0.009    9.00      95.5   0.004
  2          *β* ~0~          4.348    −0.008                        −0.18                             90.5                               0.003   −0.311   −7.16    0.0    0.099   −0.001   −0.03     61.5   0.009   −0.307   −7.07     0.0    0.102   −0.008   −0.18     87.0   0.004   −0.312   −7.17     0.0    0.100
             *β* ~1~          −0.239   −0.000                        0.08                              92.0                               0.001   0.179    −75.06   0.0    0.032   −0.001   0.25      93.0   0.001   0.180    −75.34    0.0    0.032   −0.000   0.13      92.0   0.001   0.180    −75.25    0.0    0.032
             log(*σ* ~0~)     0.133    −0.002                        0.06                              93.5                               0.002   0.009    −0.32    93.0   0.002   −0.378   14.25     0.0    0.148   −0.370   13.94     0.0    0.142   −0.032   1.20      91.0   0.004   −0.024   0.89      91.5   0.003
             log(*σ* ~1~)     −2.654   −0.002                        −1.13                             95.0                               0.001   0.004    2.83     93.5   0.001   −0.151   −113.54   0.0    0.024   −0.149   −111.90   0.0    0.024   −0.039   −29.34    58.0   0.002   −0.037   −27.46    62.5   0.002
             atanh(*ρ*)       −0.093   0.001                         −0.70                             95.0                               0.003   −0.016   17.07    93.5   0.003   0.309    −334.51   0.0    0.097   0.307    −331.72   0.0    0.095   0.138    −149.17   0.0    0.020   0.132    −142.21   1.0    0.018
             log(*σ* ~*e*~)   −0.526   0.001                         −0.10                             95.0                               0.000   0.006    −1.23    88.0   0.000   0.039    −7.50     0.0    0.002   0.046    −8.67     0.0    0.002   0.004    −0.83     93.5   0.000   0.011    −2.02     74.5   0.000
             log(*λ*)         −5.160   0.004                         −0.08                             97.5                               0.105   −0.005   0.10     97.0   0.107   0.017    −0.33     97.5   0.111   0.001    −0.02     96.5   0.113   0.006    −0.12     97.5   0.105   −0.003   0.06      97.0   0.106
             log(*γ*)         0.180    −0.008                        −4.45                             96.5                               0.006   −0.007   −3.89    96.5   0.006   −0.008   −4.45     96.0   0.006   −0.006   −3.33     96.5   0.006   −0.009   −5.00     96.5   0.006   −0.008   −4.45     96.5   0.006
             *α*              0.250    0.003                         1.20                              95.0                               0.002   0.004    1.60     95.0   0.003   −0.000   0.00      95.5   0.003   0.002    0.80      95.5   0.003   0.003    1.20      94.5   0.002   0.004    1.60      94.0   0.003
  3          *β* ~0~          4.348    −0.003                        −0.06                             93.0                               0.003   −0.286   −6.59    0.0    0.084   −0.029   −0.67     65.5   0.011   −0.320   −7.36     0.0    0.110   −0.006   −0.15     90.5   0.004   −0.295   −6.79     0.0    0.090
             *β* ~1~          −0.239   −0.000                        0.16                              96.5                               0.001   0.176    −73.50   0.0    0.031   −0.004   1.49      95.5   0.001   0.178    −74.48    0.0    0.032   −0.001   0.38      95.5   0.001   0.178    −74.65    0.0    0.032
             log(*σ* ~0~)     0.133    0.007                         −0.25                             95.0                               0.003   0.007    −0.26    93.5   0.003   −0.397   14.95     0.0    0.165   −0.409   15.42     0.0    0.176   −0.026   0.96      91.0   0.004   −0.034   1.28      91.5   0.005
             log(*σ* ~1~)     −2.654   −0.001                        −0.84                             97.0                               0.001   0.016    11.67    93.0   0.001   −0.137   −102.91   1.0    0.020   −0.129   −96.65    2.0    0.018   −0.035   −26.32    68.0   0.002   −0.026   −19.82    75.0   0.002
             atanh(*ρ*)       −0.093   −0.005                        5.55                              95.0                               0.004   −0.051   55.62    85.0   0.007   0.329    −355.80   0.0    0.110   0.328    −354.57   0.0    0.113   0.141    −152.17   1.5    0.023   0.129    −139.19   3.5    0.022
             log(*σ* ~*e*~)   −0.526   −0.000                        0.02                              96.0                               0.000   0.006    −1.16    91.5   0.000   0.038    −7.31     2.0    0.002   0.045    −8.64     0.0    0.002   0.004    −0.74     94.5   0.000   0.011    −2.09     81.5   0.000
             log(*λ*)         −5.160   −0.058                        1.12                              95.0                               0.086   −0.084   1.63     95.0   0.089   −0.037   0.72      94.0   0.084   −0.078   1.51      95.0   0.090   −0.061   1.18      95.5   0.085   −0.089   1.72      95.0   0.089
             log(*γ*)         0.180    0.010                         5.56                              94.0                               0.003   0.014    7.78     94.0   0.004   0.016    8.89      92.0   0.004   0.020    11.11     92.0   0.004   0.009    5.00      95.5   0.003   0.012    6.67      94.5   0.003
             *α*              0.500    0.005                         1.00                              94.0                               0.002   0.010    2.00     94.0   0.002   −0.004   −0.80     93.0   0.002   0.004    0.80      92.5   0.002   0.007    1.40      93.5   0.002   0.012    2.40      93.5   0.002

CP, coverage probability; MSE, mean square error; atanh, inverse hyperbolic tangent.

###### 

Simulation results of bias, percentage bias, coverage and mean square error of all parameters from rate of change association structure scenarios.

  Scenario   Parameter        Truth    5‐point adaptive quadrature   5‐point non‐adaptive quadrature   15‐point non‐adaptive quadrature                                                                                                                                                                             
  ---------- ---------------- -------- ----------------------------- --------------------------------- ---------------------------------- ------- -------- --------- ------ ------- -------- --------- ------ ------- -------- --------- ------ ------- -------- --------- ------ ------- -------- --------- ------ -------
  1          *β* ~0~          4.348    −0.003                        −0.06                             98.0                               0.002   −0.312   −7.18     0.0    0.099   −0.012   −0.27     68.8   0.012   −0.318   −7.31     0.0    0.107   −0.005   −0.11     90.9   0.004   −0.312   −7.17     0.0    0.100
             *β* ~1~          −0.239   0.000                         −0.07                             96.0                               0.001   0.180    −75.33    0.0    0.032   0.001    −0.32     96.0   0.001   0.180    −75.46    0.0    0.033   −0.000   0.02      95.5   0.001   0.180    −75.32    0.0    0.032
             log(*σ* ~0~)     0.133    0.002                         −0.07                             95.0                               0.002   0.012    −0.47     94.0   0.002   −0.366   13.79     0.0    0.139   −0.355   13.37     0.0    0.130   −0.026   0.99      91.9   0.003   −0.017   0.62      94.0   0.002
             log(*σ* ~1~)     −2.654   0.000                         0.17                              96.0                               0.001   0.002    1.37      95.0   0.001   −0.150   −112.72   0.5    0.024   −0.149   −111.93   0.5    0.024   −0.037   −27.43    63.6   0.002   −0.036   −26.95    62.0   0.002
             atanh(*ρ*)       −0.093   −0.000                        0.46                              95.0                               0.003   −0.008   8.50      93.5   0.003   0.305    −329.61   0.0    0.094   0.302    −326.27   0.0    0.092   0.133    −144.25   1.0    0.019   0.128    −138.35   0.0    0.017
             log(*σ* ~*e*~)   −0.526   −0.000                        0.06                              93.5                               0.000   0.006    −1.08     88.0   0.000   0.040    −7.52     1.0    0.002   0.045    −8.64     0.5    0.002   0.003    −0.65     92.4   0.000   0.010    −1.83     77.5   0.000
             log(*λ*)         −5.160   0.012                         −0.23                             97.0                               0.284   −0.160   3.10      98.0   0.232   −0.002   0.04      98.0   0.525   −0.117   2.27      97.0   0.225   0.002    −0.04     97.0   0.298   −0.152   2.95      98.0   0.231
             log(*γ*)         0.180    −0.013                        −7.22                             99.0                               0.020   0.005    2.78      95.5   0.016   −0.009   −5.00     98.5   0.070   0.005    2.78      95.5   0.016   −0.010   −5.56     99.0   0.023   0.005    2.78      95.5   0.016
             *α*              1.000    0.129                         12.90                             96.0                               3.373   −1.577   −157.70   87.5   8.427   0.025    2.50      96.0   6.612   −0.942   −94.20    94.5   7.940   0.086    8.60      97.0   3.415   −1.461   −146.10   88.0   8.283
  2          *β* ~0~          4.348    0.001                         0.03                              94.0                               0.003   −0.308   −7.09     0.0    0.096   −0.002   −0.03     62.5   0.009   −0.308   −7.08     0.0    0.102   −0.001   −0.02     90.5   0.003   −0.310   −7.12     0.0    0.098
             *β* ~1~          −0.239   −0.000                        0.14                              92.0                               0.001   0.180    −75.22    0.0    0.032   −0.000   0.19      90.5   0.001   0.180    −75.22    0.0    0.032   −0.000   0.14      91.0   0.001   0.180    −75.22    0.0    0.032
             log(*σ* ~0~)     0.133    −0.006                        0.24                              93.5                               0.002   0.003    −0.10     91.5   0.002   −0.367   13.84     0.0    0.139   −0.357   13.46     0.0    0.132   −0.037   1.40      86.4   0.004   −0.028   1.06      88.0   0.003
             log(*σ* ~1~)     −2.654   0.001                         0.49                              96.5                               0.001   0.002    1.65      96.0   0.001   −0.154   −115.22   1.0    0.025   −0.152   −114.28   0.0    0.025   −0.038   −28.23    59.8   0.002   −0.037   −27.41    60.5   0.002
             atanh(*ρ*)       −0.093   0.004                         −4.69                             96.0                               0.002   −0.003   3.37      95.0   0.002   0.301    −325.19   0.0    0.092   0.298    −322.48   0.0    0.090   0.139    −150.38   0.5    0.020   0.134    −145.32   0.0    0.019
             log(*σ* ~*e*~)   −0.526   −0.000                        0.01                              96.0                               0.000   0.006    −1.12     89.5   0.000   0.039    −7.39     0.0    0.002   0.045    −8.51     0.0    0.002   0.004    −0.77     92.0   0.000   0.010    −1.90     78.5   0.000
             log(*λ*)         −5.160   −0.079                        1.53                              97.5                               0.329   −0.297   5.76      93.0   0.293   −0.075   1.45      97.0   0.289   −0.268   5.19      94.0   0.274   −0.076   1.47      97.0   0.324   −0.287   5.56      93.5   0.288
             log(*γ*)         0.180    0.007                         3.89                              96.5                               0.026   0.035    19.45     95.0   0.015   0.007    3.89      97.5   0.021   0.035    19.45     94.5   0.015   0.007    3.89      97.5   0.025   0.035    19.45     95.0   0.015
             *α*              2.000    0.038                         1.90                              91.5                               3.760   −1.916   −95.80    88.5   9.180   −0.033   −1.65     92.0   3.473   −1.531   −76.55    94.5   7.972   0.042    2.10      91.5   3.601   −1.767   −88.35    93.0   8.548
  3          *β* ~0~          4.348    −0.002                        −0.05                             94.9                               0.003   −0.312   −7.18     0.0    0.099   0.003    0.06      66.5   0.008   −0.303   −6.97     0.0    0.098   −0.002   −0.05     86.4   0.008   −0.312   −7.18     0.0    0.099
             *β* ~1~          −0.239   −0.000                        0.13                              95.4                               0.001   0.180    −75.39    0.0    0.032   −0.001   0.61      93.9   0.001   0.180    −75.40    0.0    0.032   −0.000   0.15      93.9   0.001   0.180    −75.39    0.0    0.032
             log(*σ* ~0~)     0.133    −0.006                        0.22                              98.0                               0.002   0.003    −0.11     94.5   0.002   −0.368   13.86     0.0    0.139   −0.358   13.50     0.0    0.132   −0.035   1.31      89.9   0.022   −0.026   0.97      93.0   0.003
             log(*σ* ~1~)     −2.654   −0.002                        −1.13                             96.4                               0.001   −0.000   −0.21     95.0   0.001   −0.157   −118.09   0.0    0.026   −0.155   −116.40   0.0    0.025   −0.039   −29.37    56.1   0.003   −0.039   −29.36    55.5   0.002
             atanh(*ρ*)       −0.093   0.006                         −6.44                             98.0                               0.002   −0.001   1.42      96.5   0.002   0.301    −325.44   0.0    0.092   0.299    −323.11   0.0    0.090   0.138    −148.75   0.5    0.020   0.133    −143.67   0.5    0.019
             log(*σ* ~*e*~)   −0.526   0.001                         −0.11                             95.9                               0.000   0.006    −1.21     86.5   0.000   0.039    −7.50     0.0    0.002   0.045    −8.59     0.0    0.002   0.004    −0.84     89.9   0.001   0.010    −1.95     76.0   0.000
             log(*λ*)         −5.160   −0.012                        0.23                              99.0                               0.365   −0.256   4.96      94.0   0.310   −0.031   0.60      97.0   2.117   −0.242   4.69      93.0   0.319   −0.006   0.12      97.5   0.891   −0.249   4.83      94.5   0.308
             log(*γ*)         0.180    −0.010                        −5.56                             98.0                               0.030   0.025    13.89     95.0   0.019   −0.005   −2.78     96.4   0.537   0.025    13.89     95.0   0.019   −0.012   −6.67     96.5   0.153   0.025    13.89     94.5   0.019
             *α*              3.000    0.138                         4.60                              98.5                               3.126   −1.815   −60.50    86.0   9.738   −0.143   −4.77     94.4   3.717   −1.715   −57.17    92.5   9.497   0.106    3.53      95.5   8.320   −1.704   −56.80    88.0   9.109

CP, coverage probability; MSE, mean square error; atanh, inverse hyperbolic tangent.

4.1. Results -- current value {#sim6779-sec-0009}
-----------------------------

Results for the current value simulation scenarios are presented in Table [1](#sim6779-tbl-0001){ref-type="table-wrap"}. When fitting the true model, we generally find unbiased results and coverage probabilities around the optimum 95% from 5‐point adaptive quadrature across all scenarios, compared with substantial bias in estimates of variance and correlation parameters in the longitudinal submodel from 5‐point and 15‐point non‐adaptive quadrature, in particular, underestimating random effect standard deviations. For example, in scenario 1 under 5‐point adaptive quadrature, we observe 0.08% bias and 94% coverage probability in estimates of the log standard deviation of the random intercept, compared with 13.96% bias and 0.0% coverage probability from 5‐point non‐adaptive quadrature. All numerical integration techniques provide generally unbiased estimates of the association parameter, with coverage probabilities close to 95%.

Looking specifically at the 5‐point adaptive quadrature results, comparing the true model with the linear misspecified joint model, survival parameters appear to be minimally effected by the misspecification. Estimates of the association parameter appear to be generally unbiased in both the true and misspecified models. All simulations for each scenario converged except one iteration in scenario 3, with 5‐point adaptive quadrature when fitting the true model.

4.2. Results -- rate of change {#sim6779-sec-0010}
------------------------------

Results from the rate of change simulation scenarios are presented in Table [2](#sim6779-tbl-0002){ref-type="table-wrap"}. When fitting the true model, 5‐point adaptive quadrature produces results with minimal bias and with coverage probabilities broadly close to the optimum 95%. Comparing this with moderate to high levels of bias under 5‐point non‐adaptive quadrature and sub‐optimum coverage probabilities, which are slightly alleviated by 15‐point non‐adaptive quadrature, both, however, do not approach the performance of adaptive quadrature.

Looking at estimates under 5‐point adaptive quadrature and comparing between the simpler linear model and the true polynomial model, we observe substantial bias in the estimates of the association parameter (*α*) in the linear model compared with the true model. For example, in scenario 2, we observe percentage biases in estimate of −95.80*%* and 1.90% under the linear and polynomial models, respectively. This is consistent across all three scenarios.

Finally, comparing computation time under scenario 3, when *α* = 3, the median computation time to convergence on a standard laptop with 4 GB of RAM and i5 processor, with 5‐point adaptive quadrature, was 30 s (range 26, 57), compared with 114 s (range 85, 205) with 15‐point non‐adaptive. Full computation times for each scenario are not shown as the simulations were not all run on the same computer. All simulations for each scenario with the linear model converged; however, one out of 200 simulations failed to converge in each of the true model fits, across numerical integration types. Results are presented for simulations that converged.

5. Joint modelling of repeatedly measured mammographic density and breast cancer survival {#sim6779-sec-0011}
=========================================================================================

The clinical example that we use to illustrate this work comes from a population‐based, case--control study conducted in Sweden between 1993 and 1995 of patients diagnosed with breast cancer [24](#sim6779-bib-0024){ref-type="ref"}. The original study by Li *et al.* looked at change in mammographic density between baseline mammographic density measurement and first follow‐up measurement, as a prognostic marker. No modelling of mammographic density was carried out. Mammographic density, which reflects the amount of fibroglandular tissue in the breast, is one of the strongest risk factors for breast cancer [25](#sim6779-bib-0025){ref-type="ref"}. It has also been suggested that, in women diagnosed with breast cancer, change in mammography density over time may be associated with prognosis/response to treatment [24](#sim6779-bib-0024){ref-type="ref"}, [26](#sim6779-bib-0026){ref-type="ref"}. Joint modelling provides the possibility to use all available measurements during follow‐up and to learn about how mammography density changes through time as a function of treatment, accounting for dropout and measurement error, as well as providing a framework for formulating hypotheses relating to density change (as a marker of response to treatment) to survival. Because of patients having at least two measurements, they are not at risk of the event of interest until time of their second mammographic screening, and therefore, delayed entry is required. Primary interest is therefore in the rate of change association structure, shown in Equation [(4)](#sim6779-disp-0004){ref-type="disp-formula"}; however, we also investigate the current value formulation shown in Equation [(3)](#sim6779-disp-0003){ref-type="disp-formula"}, as it is the most commonly used association structure, and we can investigate whether the results shown in the simulation study are echoed in the applied analyses.

The dataset consists of 974 patients, of which 121 (12.4%) died during follow‐up. Maximum follow‐up is 15.45 years. A total of 6158 measurements of percentage mammographic density are available. The median number of mammograms per patient was 6, with a range of (2, 13). This dataset was used to inform the simulation study in the previous section. The following covariates were used in our analysis: age at diagnosis (years), body mass index (BMI) (kg/m^2^, measured at interview), tamoxifen treatment (yes/no), oestrogen receptor status (negative/positive/missing), tumour size (mm, range 1--80), number of metastatic nodes (range 0--38), grade (1 = well differentiated, 2 = moderately differentiated, 3 = poorly differentiated and 4 = missing), chemotherapy (yes/no), ever used hormone replacement therapy (yes/no) and radiotherapy (yes/no). Some missing data were present in oestrogen receptor status (27.4% missing) and grade (30.1% missing), which are included by using missing categories. In all analyses, we use the square root of percentage mammographic density to account for some right skewness, and consequently now all subsequent references to percentage mammographic density mean the square root of it. The Kaplan--Meier curve is shown in Figure [2](#sim6779-fig-0002){ref-type="fig"}.

![Kaplan--Meier survival curve of the breast cancer dataset, with 95% confidence interval.](SIM-35-1193-g002){#sim6779-fig-0002}

We begin with preliminary modelling of the survival data only, investigating the shape of the baseline hazard function using restricted cubic splines on the log hazard scale [22](#sim6779-bib-0022){ref-type="ref"}, [23](#sim6779-bib-0023){ref-type="ref"}. We use the AIC and BIC to guide the selection of the number of spline terms to capture the baseline hazard function [28](#sim6779-bib-0028){ref-type="ref"}. Results are presented in Table [3](#sim6779-tbl-0003){ref-type="table-wrap"}, with up to 5 degrees of freedom (6 knots), plus an intercept for each baseline hazard function.

###### 

AIC and BIC for spline hazard models with varying degrees of freedom (d.f.).

  d.f.   AIC       BIC
  ------ --------- ---------
  1      935.764   941.356
  2      922.638   931.025
  3      924.126   935.309
  4      925.828   939.807
  5      925.926   942.700

Table [3](#sim6779-tbl-0003){ref-type="table-wrap"} indicates that both the AIC and BIC select 2 degrees of freedom (3 knots). We illustrate the fitted baseline hazard functions in Figure [3](#sim6779-fig-0003){ref-type="fig"}.

![Predicted baseline hazard functions across differing degrees of freedom.](SIM-35-1193-g003){#sim6779-fig-0003}

When d.f.=2, we can see from Figure [3](#sim6779-fig-0003){ref-type="fig"} the presence of a turning point in the baseline hazard function, which would be missed if a simpler Weibull model would have been used.

We can also conduct preliminary separate modelling of the percentage mammographic density measurements to obtain an idea of the trend over time, to inform the full joint model. Beginning with a random intercept and random linear trend to allow for patient‐to‐patient variability, we can also investigate a more flexible trend by adding fixed polynomials of time. Results from adding a squared, cubic and quartic powers of time are shown in Table [4](#sim6779-tbl-0004){ref-type="table-wrap"}.

###### 

Longitudinal mixed effects model results for percentage mammographic density over time.

  Parameter              Estimate   Standard error   *p*‐value   95% CI    
  ---------------------- ---------- ---------------- ----------- --------- ---------
  Time                   −0.3513    0.0292           \<0.001     −0.4086   −0.2940
  Time^2^                0.0840     0.0128           \<0.001     0.0589    0.1091
  Time^3^                −0.0103    0.0019           \<0.001     −0.0141   −0.0065
  Time^4^                0.0004     0.0001           \<0.001     0.0002    0.0006
  Intercept              4.3744     0.0409           \<0.001     4.2942    4.4546
  Random effects                                                           
  sd(Time)               0.0703     0.0042                       0.0626    0.0789
  sd(Intercept)          1.1428     0.0290                       1.0874    1.2009
  corr(Time,Intercept)   −0.0918    0.0556                       −0.1993   0.0179
  sd(Residual)           0.5895     0.0063                       0.5773    0.6020

Now moving to the joint modelling framework, we apply the following joint model, based on the aforementioned separate modelling, and therefore assume that $$m_{i}\left( t \right) = \left( {\beta_{0} + b_{0i}} \right) + \left( {\beta_{1} + b_{1i}} \right)t + \beta_{2}t^{2} + \beta_{3}t^{3} + \beta_{4}t^{4}$$ modelling percentage density over time with a random intercept, random linear slope and fixed effects of time squared, cubed and to the fourth power. In the survival submodel, we use 2 degrees of freedom to model the baseline hazard function, and the rate of change (slope) association structure, as follows: $$h_{i}\left( t \right) = h_{0}\left( t \right)\exp\left\lbrack {\alpha\left( {\beta_{1} + b_{1i} + 2\beta_{2}t + 3\beta_{3}t^{2} + 4\beta_{4}t^{3}} \right)} \right\rbrack$$ with *h* ~0~(*t*) the baseline spline function. We also fit a simpler joint model, $$h_{i}\left( t \right) = h_{0}\left( t \right)\exp\left\lbrack {\alpha\left( {\beta_{1} + b_{1i}} \right)} \right\rbrack$$ assuming a random intercept and random linear trend, and compare estimates of association. However, we have a variety of important covariates that could impact on the longitudinal and survival estimates. In the longitudinal submodel, we adjust for age at diagnosis (years), BMI (kg/m^2^), ever used hormone replacement therapy (yes/no) and tumour size (mm, range 1--80), and in the survival submodel, we also adjust for age, BMI, tamoxifen treatment, oestrogen receptor status (negative/positive/missing), tumour size, number of metastatic nodes (range 0--38), grade (1 = well differentiated, 2 = moderately differentiated, 3 = poorly differentiated and 4 = missing) and chemotherapy (yes/no). Results are presented in Table [5](#sim6779-tbl-0005){ref-type="table-wrap"}, comparing the linear and polynomial models.

###### 

Full joint model results applied to the breast cancer cohort, comparing estimates of the rate of change association between the simpler linear model and the informed polynomial trajectory model.

  Parameter                 Linear   Polynomial                                                               
  ------------------------- -------- ------------ ------- -------- -------- -------- ------- ------- -------- --------
  Longitudinal                                                                                                
  Time                      −0.088   0.004        0.000   −0.096   −0.080   −0.351   0.029   0.000   −0.409   −0.294
  Time^2^                   ---      ---          ---     ---      ---      0.084    0.013   0.000   0.058    0.109
  Time^3^                   ---      ---          ---     ---      ---      −0.010   0.002   0.000   −0.014   −0.006
  Time^4^                   ---      ---          ---     ---      ---      0.000    0.000   0.000   0.000    0.001
  Age (years)               −0.029   0.006        0.000   −0.039   −0.018   −0.029   0.006   0.000   −0.040   −0.018
  BMI (kg/m^2^)             −0.110   0.009        0.000   −0.129   −0.092   −0.111   0.009   0.000   −0.129   −0.093
  HR therapy                0.003    0.071        0.972   −0.136   0.141    0.002    0.070   0.975   −0.136   0.140
  Tumour size (mm)          0.006    0.004        0.107   −0.001   0.013    0.005    0.004   0.128   −0.002   0.012
  Intercept                 8.699    0.412        0.000   7.892    9.506    8.925    0.415   0.000   8.112    9.737
  Survival                                                                                                    
  Association               4.756    4.518        0.293   −4.100   13.612   0.192    0.607   0.752   −0.998   1.382
  Age (years)               −0.024   0.017        0.159   −0.058   0.010    −0.017   0.015   0.264   −0.046   0.013
  BMI (kg/m^2^)             0.013    0.024        0.605   −0.035   0.060    0.016    0.024   0.507   −0.031   0.062
  Tamoxifen                 0.416    0.206        0.043   0.013    0.818    0.407    0.205   0.047   0.006    0.808
  ER status                 −0.416   0.259        0.108   −0.922   0.091    −0.458   0.252   0.069   −0.953   0.036
  Missing ER status         −0.382   0.313        0.223   −0.996   0.232    −0.443   0.304   0.145   −1.039   0.153
  Tumour size (mm)          0.026    0.008        0.001   0.011    0.041    0.024    0.007   0.001   0.010    0.039
  No. of metastatic nodes   0.087    0.014        0.000   0.059    0.116    0.088    0.013   0.000   0.062    0.115
  Grade = 2                 0.610    0.446        0.172   −0.265   1.485    0.617    0.445   0.166   −0.256   1.489
  Grade = 3                 0.490    0.453        0.279   −0.398   1.377    0.516    0.451   0.253   −0.368   1.399
  Grade = Missing           0.616    0.447        0.168   −0.260   1.492    0.647    0.445   0.146   −0.225   1.520
  Chemotherapy              0.238    0.318        0.454   −0.385   0.861    0.231    0.312   0.460   −0.381   0.842
  Spline 1                  −0.028   0.136        0.836   −0.294   0.238    −0.064   0.156   0.682   −0.371   0.242
  Spline 2                  0.177    0.127        0.162   −0.071   0.426    0.214    0.171   0.212   −0.122   0.549
  Intercept                 −4.035   1.414        0.004   −6.806   −1.264   −4.910   1.126   0.000   −7.117   −2.703
  Random effects                                                                                              
  sd(Time)                  0.069    0.004        ---     0.061    0.078    0.070    0.004   ---     0.063    0.079
  sd(Intercept)             1.025    0.027        ---     0.974    1.079    1.026    0.027   ---     0.975    1.080
  corr(Time,Intercept)      −0.007   0.061        ---     −0.126   0.112    −0.005   0.060   ---     −0.122   0.112
  sd(Residual)              0.601    0.006        ---     0.589    0.614    0.589    0.006   ---     0.577    0.602

BMI, body mass index; ER, oestrogen receptor; HR, hormone replacement.

From Table [5](#sim6779-tbl-0005){ref-type="table-wrap"}, looking at the polynomial‐based model, we observe no statistically significant association between the rate of change of percentage mammographic density over time and breast cancer survival, with an association estimate of 0.192 (95% CI: −0.998, 1.382). We find a marked difference in the estimates of association when assuming a simpler longitudinal trajectory, with an estimated association of 4.756 (95% CI: −4.100, 13.612). We also note that as the association estimate is non‐statistically significant, we obtain identical estimates of the random effects, to 3 decimal places, to those from the separate longitudinal model shown in Table [4](#sim6779-tbl-0004){ref-type="table-wrap"}.

We now fit joint models with the current value association structure, comparing the polynomial longitudinal trajectory model, $$h_{i}\left( t \right) = h_{0}\left( t \right)\exp\left\lbrack {\alpha\left( {\beta_{0} + b_{0i} + \left( \beta_{1} + b_{1i} \right)t + \beta_{2}t^{2} + \beta_{3}t^{3} + \beta_{4}t^{4}} \right)} \right\rbrack$$ with the simpler linear trajectory model, $$h_{i}\left( t \right) = h_{0}\left( t \right)\exp\left\lbrack {\alpha\left( \beta_{0} + b_{0i} + \left( \beta_{1} + b_{1i} \right)t \right)} \right\rbrack$$ and compare estimates of association. Results are presented in Table [6](#sim6779-tbl-0006){ref-type="table-wrap"}

###### 

Full joint model results applied to the breast cancer cohort, comparing estimates of the current value association between the simpler linear model and the informed polynomial trajectory model.

  Parameter                 Linear   Polynomial                                                               
  ------------------------- -------- ------------ ------- -------- -------- -------- ------- ------- -------- --------
  Longitudinal                                                                                                
  Time                      −0.090   0.004        0.000   −0.097   −0.082   −0.351   0.029   0.000   −0.409   −0.294
  Time^2^                   ---      ---          ---     ---      ---      0.084    0.013   0.000   0.059    0.109
  Time^3^                   ---      ---          ---     ---      ---      −0.010   0.002   0.000   −0.014   −0.006
  Time^4^                   ---      ---          ---     ---      ---      0.000    0.000   0.000   0.000    0.001
  Age (years)               −0.028   0.006        0.000   −0.039   −0.018   −0.029   0.006   0.000   −0.040   −0.018
  BMI (kg/m^2^)             −0.110   0.009        0.000   −0.129   −0.092   −0.111   0.009   0.000   −0.129   −0.092
  HR therapy                0.000    0.071        1.000   −0.138   0.138    0.002    0.070   0.982   −0.137   0.140
  Tumour size (mm)          0.006    0.004        0.110   −0.001   0.013    0.006    0.004   0.121   −0.001   0.013
  Intercept                 8.697    0.412        0.000   7.890    9.504    8.925    0.415   0.000   8.112    9.738
  Survival                                                                                                    
  Association               0.105    0.087        0.226   −0.065   0.275    0.106    0.083   0.202   −0.057   0.268
  Age (years)               −0.015   0.015        0.307   −0.045   0.014    −0.015   0.015   0.305   −0.045   0.014
  BMI (kg/m^2^)             0.028    0.025        0.274   −0.022   0.077    0.028    0.025   0.270   −0.021   0.077
  Tamoxifen                 0.409    0.205        0.045   0.008    0.810    0.408    0.205   0.046   0.007    0.809
  ER status                 −0.487   0.251        0.053   −0.980   0.006    −0.488   0.251   0.052   −0.980   0.005
  Missing ER status         −0.457   0.303        0.132   −1.051   0.138    −0.458   0.303   0.131   −1.052   0.137
  Tumour size (mm)          0.024    0.007        0.001   0.010    0.038    0.024    0.007   0.001   0.010    0.038
  No. of metastatic nodes   0.088    0.013        0.000   0.062    0.115    0.088    0.013   0.000   0.062    0.115
  Grade = 2                 0.600    0.445        0.178   −0.272   1.473    0.600    0.445   0.178   −0.273   1.472
  Grade = 3                 0.489    0.452        0.279   −0.396   1.374    0.487    0.452   0.281   −0.398   1.372
  Grade = Missing           0.600    0.447        0.180   −0.276   1.476    0.599    0.447   0.180   −0.277   1.475
  Chemotherapy              0.253    0.312        0.417   −0.358   0.864    0.254    0.312   0.415   −0.357   0.865
  Spline 1                  −0.006   0.138        0.964   −0.276   0.264    −0.030   0.136   0.827   −0.297   0.237
  Spline 2                  0.160    0.129        0.213   −0.092   0.413    0.206    0.130   0.112   −0.048   0.461
  Intercept                 −5.636   1.269        0.000   −8.125   −3.148   −5.654   1.262   0.000   −8.128   −3.181
  Random effects                                                                                              
  sd(Time)                  0.069    0.004        ---     0.061    0.078    0.070    0.004   ---     0.063    0.079
  sd(Intercept)             1.027    0.027        ---     0.976    1.081    1.027    0.027   ---     0.975    1.080
  corr(Time,Intercept)      −0.015   0.061        ---     −0.133   0.104    −0.005   0.060   ---     −0.122   0.112
  sd(Residual)              0.601    0.006        ---     0.589    0.614    0.589    0.006   ---     0.577    0.602

BMI, body mass index; ER, oestrogen receptor; HR, hormone replacement.

From Table [6](#sim6779-tbl-0006){ref-type="table-wrap"}, under the full joint model with polynomial trajectory, we find a non‐statistically significant association of 0.106 (95% CI: −0.057, 0.268). We observe a very similar association estimate from the simpler linear model, 0.105 (95% CI: −0.065, 0.275), in agreement with the findings of the simulation study, showing the robustness of the current value association.

All Stata do files used in the simulation study, and applied joint model analyses of the breast cancer data are included in the [Supporting Information](#sim6779-supinf-0001){ref-type="supplementary-material"}.

6. Discussion {#sim6779-sec-0012}
=============

In this article, we proposed a flexible joint model incorporating delayed entry (left truncation), using restricted cubic splines to model the baseline hazard function, and (fractional) polynomials in the longitudinal submodel to capture complex trajectories of biomarkers over time. The addition of delayed entry required a second set of numerical integration beyond that of the standard joint model. We proposed to use fully adaptive quadrature to evaluate the likelihood, as an alternative to previously proposed non‐adaptive quadrature.

Through simulation, we investigated the performance of fully adaptive Gauss--Hermite quadrature in calculating the joint likelihood, comparing it with non‐adaptive quadrature. Our results showed substantial improvement in terms of bias and coverage under the adaptive routines, particularly in estimates of longitudinal submodel parameters. In order to achieve similar performance as the adaptive routines, it is expected that a minimum of 30 quadrature points would be required, as has been found in standard joint models [21](#sim6779-bib-0021){ref-type="ref"}. In terms of computation time, this is an important issue. For example, comparing computation time under scenario 3 with the rate of change association structure, when *α* = 3, the median computation time to convergence on a standard laptop with 4 GB of RAM and an i5 processor, with 5‐point adaptive quadrature, was 30 s (range 26, 57), compared with 114 s (range 85, 205) with 15‐point non‐adaptive. If 30‐point non‐adaptive quadrature is required, then this difference will clearly grow further. This is an important consideration as joint models begin to be used on larger registry‐based datasets where the number of patients may be in the tens of thousands, not hundreds.

We also investigated the impact of misspecifying the longitudinal trajectory through simulation, an issue that we believe has not been investigated before. We used scenarios that were based on a cubic polynomial trajectory longitudinal submodel fitted to the breast cancer data, and subsequently fitted the true joint model, and a more simplistic random intercept and random linear slope longitudinal submodel. We assessed the impact of misspecifying the trajectory under both the current value association and the rate of change association structures. In our scenarios, we found the current value association structure to be quite robust to the misspecification. Conversely, we found the rate of change association structure to be very sensitive, with substantial bias present in estimates of the association parameter when the simpler linear trajectory was fitted. Given the assumed trajectory, shown in Figure [1](#sim6779-fig-0001){ref-type="fig"}b, it appears that under the current value association structure, the linear approximation to the more complex true cubic shape did not impact greatly. Conversely, assuming a constant rate of change when the truth is a more complex squared function impacted greatly. If a more complex shape had been chosen for the trajectory, for example, incorporating a turning point within the range of the data, we expect the current value to be as sensitive to misspecification. Another aspect of the longitudinal trajectory that we could have investigated is the assumption of normally distributed random effects; however, multiple authors have found joint models quite robust to deviations from this assumption [36](#sim6779-bib-0036){ref-type="ref"}, [37](#sim6779-bib-0037){ref-type="ref"}.

We illustrated the methodology with an example in breast cancer, where primary interest was in the association between change in mammographic density over time and breast cancer survival. It built on previous work that looked at change in mammographic density between the scan at diagnosis and the first follow‐up scan. In the joint model analysis, we were mainly interested in the current slope or current value association structures (Equation [(4)](#sim6779-disp-0004){ref-type="disp-formula"}) to link density change to survival. In a future study, we will use the joint modelling framework to explore other, perhaps more clinically relevant, association structures. Discrepancy between our results and those in Li *et al.* may be due to the fact that they focus on the impact of density change close to diagnosis. We have here focused on developing the joint modelling framework for this dataset with delayed entry that can incorporate all follow‐up density measurements/model density as a longitudinal outcome. In line with the simulation study, we also compared the robustness of the rate of change, and current value association structures to using a simpler longitudinal trajectory compared with the separate modelling‐informed polynomial trajectory. Results from the applied analyses indicated complete agreement to those found in the simulation study, showing robustness of the association parameter, compared with a substantial lack of robustness in the rate of change specification. An important limitation to note is that in our model framework, we do not consider time‐dependent feedback. This may occur, for example, if tamoxifen therapy affected mammographic density, which, subsequently, affected whether a patient was then asked to take or discontinue tamoxifen. However, we only had information on whether a patient was taking tamoxifen or not, at baseline, and had no information on adherence.

In our application, we used preliminary separate modelling, utilising the AIC and BIC to guide the selection of the functional form of both the longitudinal trajectory and the baseline hazard function. We did not include this approach within the simulation study where we fitted the true and a misspecified model, which is a limitation. In applied studies, we do not know the truth, and therefore, some form of model selection must be used. The optimal method to select both these functional forms is an area of further research [38](#sim6779-bib-0038){ref-type="ref"}.

For the time‐to‐event outcome, we used restricted cubic splines on the log hazard scale to model the baseline hazard function, with knot selection guided by the AIC and BIC, which has been shown to be an effective model‐building strategy [28](#sim6779-bib-0028){ref-type="ref"}. It must be noted that sensitivity analyses should be conducted to assess the impact of the number of degrees of freedom used to model both the baseline and indeed the longitudinal trajectory. Alternative flexible formulations could have been explored, for example, Proust‐Lima *et al.* used penalised cubic *M*‐splines on the hazard scale [20](#sim6779-bib-0020){ref-type="ref"}. We could have used age as the timescale in our illustrative example but in this case time because diagnosis can be considered the more appropriate timescale to use; however, in many examples, a delayed entry joint model will be required when using age as the timescale.

In our analyses, we used missing indicator variables for covariates with any missing data present, allowing us to use the full dataset. This is clearly not ideal, and therefore, incorporating a multiple imputation approach suitable for use in a joint modelling framework would be a very useful area of future research. A Bayesian approach may also be of use in this context. Extensions to the modelling framework also include incorporating multiple longitudinal outcomes, within a generalised linear mixed longitudinal submodel that would allow also binary and Poisson outcomes. Furthermore, the extension to a multi‐state survival submodel would allow event‐specific associations between complex longitudinal profiles and multiple events. Alternatives to the joint modelling framework could be investigated and compared, such as the use of inverse probability weights to account for dropout or regression calibration approaches; however, they give focus to either the longitudinal or survival components, whereas a joint model allows the elucidation of inferences to be drawn about both processes simultaneously.
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